BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

HORIZON PHARMA — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

HORIZON PHARMA

via BGR GOVERNMENT AFFAIRS

2nd Quarter (Apr 1 - June 30) · 2023Posted Jul 20, 2023Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: HORIZON PHARMA
Description: Biopharmaceuticals
Location: Illinois · United States of America

Registrant

Firm: BGR GOVERNMENT AFFAIRS
Description: Lobbying firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
Provide guidance and advocacy with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Horizon specifically.
LobbyistsBRENT ALAN DEL MONTE · ROBB WALTON · JOHN STONE · DANIEL FARMER · JOEL D. BAILEY · ms REMY LEIGH BRIM MASON
Covered position (BRENT ALAN DEL MONTE): See prior filing
Covered position (ROBB WALTON): See prior filing
Covered position (JOHN STONE): See prior filing
Covered position (DANIEL FARMER): See prior filing
Covered position (JOEL D. BAILEY): See prior filing
Covered position (ms REMY LEIGH BRIM MASON): See prior filing
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.